polo-like kinase-1 inhibitors (Chroma Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepolo-like kinase-1 inhibitors (Chroma Therapeutics)
Drug Alias NamePLK-1 inhibitors (Chroma Therapeutics)CHR-4125CHR-4146CHR-5010
ClassificationSmall molecules
Mechanisms of ActionPolo like kinase 1 inhibitorsAnticancer protein kinase inhibitorsApoptosis stimulants
TargetsPolo like kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChroma Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChroma Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A